Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Albert Chi-Yan Chan"'
Autor:
Keith Wan Hang Chiu, Chi Leung Chiang, Kenneth Sik Kwan Chan, Yuan Hui, Jingyun Ren, Xiaojuan Wei, Kwok Sing Ng, Ho Fun Victor Lee, Nam Hung Chia, Tan-To Cheung, Stephen Chan, Albert Chi-Yan Chan, Kwok Chai Kelvin Ng, Wai Kay Walter Seto, Pek-Lan Khong, Feng-Ming Kong
Publikováno v:
JHEP Reports, Vol 6, Iss 7, Pp 101099- (2024)
Background & Aims: Combined 18F-fluorodeoxyglucose (FDG) and 11C-acetate (dual-tracer) positron-emission tomography/computed tomography (PET/CT) is being increasingly performed for the management of hepatocellular carcinoma (HCC), although its role i
Externí odkaz:
https://doaj.org/article/fb1722525b5845439f13ab95b848b401
Autor:
Yu-Man Tsui, Daniel Wai-Hung Ho, Karen Man-Fong Sze, Joyce Man-Fong Lee, Eva Lee, Qingyang Zhang, Gary Cheuk-Hang Cheung, Chung-Ngai Tang, Victor Wai-Lun Tang, Elaine Tin-Yan Cheung, Irene Lai-Oi Lo, Albert Chi-Yan Chan, Tan-To Cheung, Irene Oi-Lin Ng
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 18, Iss 3, Pp 101358- (2024)
Background & Aims: Hepatocellular carcinoma (HCC) is a heterogeneous cancer with varying levels of liver tumor initiating or cancer stem cells in the tumors. We aimed to investigate the expression of different liver cancer stem cell (LCSC) markers in
Externí odkaz:
https://doaj.org/article/d5a5192378254ec88c9bf87ad3bb3e2d
Autor:
Charles Shing Kam, Daniel Wai-Hung Ho, Vanessa Sheung-In Ming, Lu Tian, Karen Man-Fong Sze, Vanilla Xin Zhang, Yu-Man Tsui, Abdullah Husain, Joyce Man-Fong Lee, Carmen Chak-Lui Wong, Albert Chi-Yan Chan, Tan-To Cheung, Lo-Kong Chan, Irene Oi-Lin Ng
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 15, Iss 6, Pp 1325-1350 (2023)
Background & Aims: Metabolic reprogramming is recognized as a cancer hallmark intimately linked to tumor hypoxia, which supports rapid tumor growth and mitigates the consequential oxidative stress. Phosphofructokinase-fructose bisphosphatase (PFKFB)
Externí odkaz:
https://doaj.org/article/4caaf380883542f299e658fda3245384
Autor:
Kristy Kwan‐Shuen Chan, Kwan‐Yung Au, Wai‐Ching Fung, Cheuk‐Yan Wong, Albert Chi‐Yan Chan, Regina Cheuk‐Lam Lo
Publikováno v:
Hepatology Communications, Vol 6, Iss 12, Pp 3473-3486 (2022)
Abstract Liver cirrhosis represents an advanced stage of chronic liver disease and is associated with significant morbidity, mortality, and risk of cancer development. While sex disparity of liver diseases has been observed, understanding at a geneti
Externí odkaz:
https://doaj.org/article/3f3c0dfce4df469f95a5bd79d1991808
Autor:
Daniel Wai-Hung Ho, Yu-Man Tsui, Lo-Kong Chan, Karen Man-Fong Sze, Xin Zhang, Jacinth Wing-Sum Cheu, Yung-Tuen Chiu, Joyce Man-Fong Lee, Albert Chi-Yan Chan, Elaine Tin-Yan Cheung, Derek Tsz-Wai Yau, Nam-Hung Chia, Irene Lai-Oi Lo, Pak-Chung Sham, Tan-To Cheung, Carmen Chak-Lui Wong, Irene Oi-Lin Ng
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Different cells of the tumour microenvironment in HBV-associated human hepatocellular carcinoma (HCC) interact to promote tumour immunity. Here the authors use single cell RNA sequencing to identify TIGIT-NECTIN2 as a pathway by which tumour-associat
Externí odkaz:
https://doaj.org/article/f985f3f45e114476aff8ed39645b53e3
Publikováno v:
Cancers, Vol 15, Iss 4, p 1105 (2023)
This study aims to investigate the association of pre-treatment multi-phasic MR-based radiomics and dosimetric features with treatment response to a novel sequential trans-arterial chemoembolization (TACE) plus stereotactic body radiotherapy (SBRT) p
Externí odkaz:
https://doaj.org/article/2cae9c042e3a4594b868718a3caeba73
Autor:
Chi-Leung Chiang, Keith Wan-Hang Chiu, Francis Ann-Shing Lee, Feng-Ming Spring Kong, Albert Chi-Yan Chan
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Immunotherapy has achieved modest clinical activity in HCC patients. Propensity score matching analysis was conducted to compare the efficacy and safety of combined stereotactic SBRT-IO versus TACE in patients with locally advanced HCC in a tertiary
Externí odkaz:
https://doaj.org/article/f257664e8cdd484abb5eda29a6c55e4e
Autor:
Kin-Pan Au, FRCS, Wing-Chiu Dai, FRCS, Albert Chi-Yan Chan, MS, Tan-To Cheung, MS, Chung-Mau Lo, MS, Kenneth Siu-Ho Chok, MS
Publikováno v:
Transplantation Direct, Vol 7, Iss 10, p e769 (2021)
Background. Precise staging is essential in the management of patients with recurrent hepatocellular carcinoma (HCC) after liver transplantation. There is no current consensus on the optimal staging strategy. We conducted this study to evaluate the p
Externí odkaz:
https://doaj.org/article/ee01e2d391d1437a9a999c348f47db20
Autor:
Kin-Pan Au, James Yan-Yue Fung, Wing-Chiu Dai, Albert Chi-Yan Chan, Chung-Mau Lo, Kenneth Siu-Ho Chok
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 15, p 4389 (2022)
It is uncertain whether tumour biology affects radical treatment for post-transplant hepatocellular carcinoma (HCC) oligo-recurrence, i.e. recurrence limited in numbers and locations amendable to radical therapy. We conducted a retrospective study on
Externí odkaz:
https://doaj.org/article/efe8c87c559d42f9944e967ae992f471
Autor:
Ivan Fan-Ngai Hung, Danny Ka-Ho Wong, Ronnie Tung-Ping Poon, Daniel Yee-Tak Fong, Ada Hang-Wai Chui, Wai-Kay Seto, James Yan-Yue Fung, Albert Chi-Yan Chan, John Chi-Hang Yuen, Randal Tiu, Olivia Choi, Ching-Lung Lai, Man-Fung Yuen
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148493 (2016)
Independent risk factors associated with hepatitis B (HBV)-related hepatocellular carcinoma (HCC) after resection remains unknown. An accurate risk score for HCC recurrence is lacking.We prospectively followed up 200 patients who underwent liver rese
Externí odkaz:
https://doaj.org/article/a3dd3a87fbdd46319c6ccb5329bb8bfc